Early Versus Delayed Timing of Intervention in Patients With Acute Coronary Syndromes

NCT00552513 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3031

Last updated 2022-04-21

Study results available
· View outcomes & findings →

Summary

The timing of intervention study is a prospective, randomized, international, multicentre comparison of the relative efficacy, safety, and cost effectiveness of a management strategy of coronary angiography and intervention performed within 24 hours of randomization versus delayed coronary angiography and intervention in patients after 36 hours with acute coronary syndromes (ACS).

Conditions

Interventions

PROCEDURE

Early Coronary Intervention

Perform coronary angiography and intervention (either percutaneous coronary intervention \[PCI\] or coronary artery bypass graft \[CABG\] surgery) as soon as possible (and within 24 hours of randomisation).

PROCEDURE

Delayed Coronary Intervention

Perform coronary angiography and intervention (either percutaneous coronary intervention \[PCI\] or coronary artery bypass graft \[CABG\] surgery) any time after 36 hours after randomisation.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • Hamilton Health Sciences Corporation

    collaborator OTHER
  • Population Health Research Institute

    lead OTHER

Principal Investigators

  • Shamir Mehta, MD, MSc · Population Health Research Institute, Hamilton Health Sciences, McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2008-07-31
Completion
2009-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00552513 on ClinicalTrials.gov